Reduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy

Roger, A.; Arcalá Campillo, E.; Torres, M. C.; Millan, C.; Jáuregui, I.; Mohedano, E.; Liñan, S.; Verdu, P.; Rubira, N.; Santaolalla, M.; González, P.; Orovitg, A.; Villarrubia, E.

doi:10.1186/s13223-016-0146-9

Table 5 Factors potentially associated with satisfaction with AIT (ESPIA) according to the bivariate and simple regression models

From: Reduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy

Factors	Satisfaction with AIT (ESPIA)
	Adults working					Adults studying
	n	Bivariate analysis			Simple Regression	n	Bivariate analysis			Simple regression#
	n	Mean score	SD	P value*	Beta coefficient	n	Mean score	SD	P value*	Beta coefficient
Age (years)
<35	180	63.01	25.64	0.040	Excluded	96	65.43	24.3	0.495	Excluded
≥35	206	68.08	24.44	0.040	Excluded	6	62.19	17.38	0.495	Excluded
Sex
Male	200	66.18	26.49	0.347		45	62.12	25.89	0.35	8.491
Female	186	65.21	23.58	0.347		57	67.71	22.11	0.35	8.491
Educational level
Basic literacy	6	69.79	25.52	0.924		2	42.19	26.52	0.167	Excluded
Primary level	51	64.65	24.38			5	44.06	37.41
Secondary level	139	65.19	25.85			56	64.52	22.08
Completed university
Duration of AR (years)
<9	194	67.88	24.09	0.095		62	67.42	22.68	0.374	Excluded
≥9	190	63.67	25.57	0.095		39	61.89	25.91	0.374	Excluded
Etiologic allergen
Dust mite	111	62.49	25.32	0.118		37	62.4	26.8	0.976	6.757
Pollen	190	66.68	25.27			41	63.9	21.27
Both	75	67.51	25			21	75.72	18.44
Familiar history of atopy
Yes	214	64.81	26.59	0.689		68	66.11	23.72	0.766	Excluded
No	166	67.17	23.06	0.689		33	64.77	23.73	0.766	Excluded
Number of visits to allergist
<3	196	66.07	24.76	0.888		57	65.44	22.73	0.898	Excluded
≥3	187	65.22	25.49	0.888		45	64.98	25.54	0.898	Excluded
Type of AR
Intermittent	118	74.19	20.92	0.000	−9.232	36	71.01	19.02	0.123	−10.012
Persistent	268	61.98	25.9	0.000	−9.232	65	62.5	25.75	0.123	−10.012
VALERO severity
Mild	66	78.6	20.61	0.000	−4.308	14	75.68	23.63	0.079	Excluded
Moderate	205	63.84	24.7			64	65.65	22.17
Severe	115	61.66	25.98			24	58.05	26.91
His tory of allergy
No	48	66.71	21.47	0.85		13	56.88	27.74	0.223	Excluded
Yes	338	65.57	25.6	0.85		89	66.46	23.2	0.223	Excluded
Type AIT
SCIT	231	66.73	26.36	0.184		54	63.28	26.72	0.845	Excluded
SLIT	141	65.19	22.79	0.184		41	67.03	19.43	0.845	Excluded

“Excluded” are the factors discarded by the regression model as potentially associated with productivity impairment
Mean overall scores of the ESPIA questionnaire are obtained from the sum of its items with transformation to a 0–100-point scale
Significance values are in italics
AIT allergen immunotherapy, AR allergic rhinitis, SD standard deviation
* P-value for the bivariate analysis was calculated using Mann–Whitney or Kruskal–Wallis tests for independent samples, with a confidence interval of 95 %
^# In the population of adult students, all variables were included in the simple regression due to lack of significance in the initial bivariate analysis

Back to article page

ISSN: 1710-1492

Contact us

Submission enquiries: shanmathi.ethiraj@springernature.com
General enquiries: info@biomedcentral.com

Allergy, Asthma & Clinical Immunology

Contact us